Comcast has officially filed its intent to acquire Time Warner Cable with the Federal Communications Commission, but in its latest filing the company is accusing several companies of extortion.
According to reports, Comcast claims Discovery Communications is trying to extort favorable conditions in exchange for not opposing Comcast’s merger with TWC. Specifically, the cable group is accusing Discovery of demanding business concessions. “Such extortionate demands are patently improper,” Comcast said. “As the self-proclaimed ‘#1 Pay-TV Programmer in the World,’ Discovery does not need additional regulatory help to succeed in the marketplace.”
Discovery approached the FCC with concerns over the Comcast deal several weeks ago, according to reports, saying that the merger “could result in lower quality, less diverse programming and fewer independent voices among programmers.”
Comcast also accused Cogent Communications and advertising company Viamedia of similarly trying to extort favorable advantages from the merger.
Reports say the FCC is expected to approve of the $45 billion takeover, but Comcast will likely be required to agree to significant concessions to move the deal forward.
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas